Adeno-associated Virus as a Gene Therapy Vector: Vector Development, Production and Clinical Applications

  • Joshua C. Grieger
  • Richard J. Samulski
Part of the Advances in Biochemical Engineering/Biotechnology book series (ABE, volume 99)


Adeno-associated virus (AAV) has emerged as an attractive vector for gene therapy. AAV vectors have successfully been utilized to promote sustained gene expression in a variety of tissues such as muscle, eye, brain, liver, and lung [1, 2, 3, 4, 5, 6, 7]. As the significance of AAV as a gene therapy vector has been realized over the past years, recent developments in recombinant AAV (rAAV) production and purification have revolutionized the AAV field. It is now possible to produce high yields of vector (1012–1013 genome-containing particles per mL) that are free of contaminating cellular and helper virus proteins. Such vectors have been successfully used in preclinical applications in animal models such as those of hemophilia, lysosomal storage diseases and vision deficiency, all of which have shown therapeutic benefits from rAAV treatment. Clinical trials using rAAV2 for the treatment of hemophilia B, cystic fibrosis, alpha-1-antitrypsin deficiency, and Canavan disease have begun, and reports from these phase I trials support the safety seen in preclinical trials. Eventually, tissue-specific vectors that can potentially evade the immune system will be required to optimize success in gene therapy. In recent years, this has led to the development of retargeted rAAV2 vectors and the identification and characterization of new serotypes from human and nonhuman primates that could potentially achieve these goals. AAV virologists and gene therapists alike have just begun to scratch the surface in terms of the utility of this small virus in a clinical setting. In this chapter, we will provide a comprehensive overview of the recent advances in rAAV vector production and purification, vector development, and clinical applications.

Adeno-associated virus Adenovirus Heparan sulfate proteoglycan Transfection Herpes simplex virus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Xiao X, Li J, McCown TJ, Samulski RJ (1997) Exp Neurol 144:113 CrossRefGoogle Scholar
  2. 2.
    Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA (1997) Nat Genet 16:270 CrossRefGoogle Scholar
  3. 3.
    Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB, Carter BJ (1993) P Natl Acad Sci USA 90:10613 CrossRefGoogle Scholar
  4. 4.
    Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K, Pathak R, Raper SE, Wilson JM (1997) Nat Med 3:306 CrossRefGoogle Scholar
  5. 5.
    Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM, Jacobson SG, Hauswirth WW, Bennett J (2001) Nat Genet 28:92 CrossRefGoogle Scholar
  6. 6.
    Auricchio A (2003) Vision Res 43:913 CrossRefGoogle Scholar
  7. 7.
    Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X, Samulski RJ (2002) J Virol 76:791 CrossRefGoogle Scholar
  8. 8.
    Atchison RW, Casto BC, Hammon WM (1965) Science 149:754 CrossRefGoogle Scholar
  9. 9.
    Buller RM, Janik JE, Sebring ED, Rose JA (1981) J Virol 40:241 Google Scholar
  10. 10.
    Srivastava A, Lusby EW, Berns KI (1983) J Virol 45:555 Google Scholar
  11. 11.
    Lusby E, Fife KH, Berns KI (1980) J Virol 34:402 Google Scholar
  12. 12.
    King JA, Dubielzig R, Grimm D, Kleinschmidt JA (2001) Embo J 20:3282 CrossRefGoogle Scholar
  13. 13.
    Chejanovsky N, Carter BJ (1989) Virology 173:120 CrossRefGoogle Scholar
  14. 14.
    Girod A, Wobus CE, Zadori Z, Ried M, Leike K, Tijssen P, Kleinschmidt JA, Hallek M (2002) J Gen Virol 83:973 Google Scholar
  15. 15.
    Zadori Z, Szelei J, Lacoste MC, Li Y, Gariepy S, Raymond P, Allaire M, Nabi IR, Tijssen P (2001) Dev Cell 1:291 CrossRefGoogle Scholar
  16. 16.
    Warrington KH Jr, Gorbatyuk OS, Harrison JK, Opie SR, Zolotukhin S, Muzyczka N (2004) J Virol 78:6595 CrossRefGoogle Scholar
  17. 17.
    Muzyczka N (1992) Curr Top Microbiol Immunol 158:97 Google Scholar
  18. 18.
    Berns KI, Linden RM (1995) Bioessays 17:237 CrossRefGoogle Scholar
  19. 19.
    Samulski RJ, Zhu X, Xiao X, Brook JD, Housman DE, Epstein N, Hunter LA (1991) Embo J 10:3941 Google Scholar
  20. 20.
    Kotin RM, Berns KI (1989) Virology 170:460 CrossRefGoogle Scholar
  21. 21.
    Cheung AK, Hoggan MD, Hauswirth WW, Berns KI (1980) J Virol 33:739 Google Scholar
  22. 22.
    Laughlin CA, Cardellichio CB, Coon HC (1986) J Virol 60:515 Google Scholar
  23. 23.
    McLaughlin SK, Collis P, Hermonat PL, Muzyczka N (1988) J Virol 62:1963 Google Scholar
  24. 24.
    Chang LS, Shi Y, Shenk T (1989) J Virol 63:3479 Google Scholar
  25. 25.
    Samulski RJ, Shenk T (1988) J Virol 62:206 Google Scholar
  26. 26.
    Janik JE, Huston MM, Rose JA (1981) P Natl Acad Sci USA 78:1925 CrossRefGoogle Scholar
  27. 27.
    Laughlin CA, Jones N, Carter BJ (1982) J Virol 41:868 Google Scholar
  28. 28.
    Richardson WD, Westphal H (1984) J Virol 51:404 Google Scholar
  29. 29.
    Carter BJ, Antoni BA, Klessig DF (1992) Virology 191:473 CrossRefGoogle Scholar
  30. 30.
    Chang LS, Shenk T (1990) J Virol 64:2103 Google Scholar
  31. 31.
    Weindler FW, Heilbronn R (1991) J Virol 65:2476 Google Scholar
  32. 32.
    Samulski RJ, Chang LS, Shenk T (1989) J Virol 63:3822 Google Scholar
  33. 33.
    Vincent KA, Piraino ST, Wadsworth SC (1997) J Virol 71:1897 Google Scholar
  34. 34.
    Ogasawara Y, Urabe M, Ozawa K (1998) Microbiol Immunol 42:177 Google Scholar
  35. 35.
    Li J, Samulski RJ, Xiao X (1997) J Virol 71:5236 Google Scholar
  36. 36.
    Grimm D, Kern A, Rittner K, Kleinschmidt JA (1998) Hum Gene Ther 9:2745 CrossRefGoogle Scholar
  37. 37.
    Collaco RF, Cao X, Trempe JP (1999) Gene 238:397 CrossRefGoogle Scholar
  38. 38.
    Xiao X, Li J, Samulski RJ (1998) J Virol 72:2224 Google Scholar
  39. 39.
    Clark KR, Voulgaropoulou F, Fraley DM, Johnson PR (1995) Hum Gene Ther 6:1329 CrossRefGoogle Scholar
  40. 40.
    Ruffing M, Zentgraf H, Kleinschmidt JA (1992) J Virol 66:6922 Google Scholar
  41. 41.
    Chen C, Okayama H (1987) Mol Cell Biol 7:2745 Google Scholar
  42. 42.
    Ferrari FK, Samulski T, Shenk T, Samulski RJ (1996) J Virol 70:3227 Google Scholar
  43. 43.
    McCarty DM, Christensen M, Muzyczka N (1991) J Virol 65:2936 Google Scholar
  44. 44.
    Pereira DJ, McCarty DM, Muzyczka N (1997) J Virol 71:1079 Google Scholar
  45. 45.
    Pereira DJ, Muzyczka N (1997) J Virol 71:4300 Google Scholar
  46. 46.
    Pereira DJ, Muzyczka N (1997) J Virol 71:1747 Google Scholar
  47. 47.
    Matsushita T, Elliger S, Elliger C, Podsakoff G, Villarreal L, Kurtzman GJ, Iwaki Y, Colosi P (1998) Gene Ther 5:938 Google Scholar
  48. 48.
    Salvetti A, Oreve S, Chadeuf G, Favre D, Cherel Y, Champion-Arnaud P, David-Ameline J, Moullier P (1998) Hum Gene Ther 9:695 CrossRefGoogle Scholar
  49. 49.
    Zhang X, De Alwis M, Hart SL, Fitzke FW, Inglis SC, Boursnell ME, Levinsky RJ, Kinnon C, Ali RR, Thrasher AJ (1999) Hum Gene Ther 10:2527 CrossRefGoogle Scholar
  50. 50.
    Clark KR (2002) Kidney Int 61 Suppl 1:9 CrossRefGoogle Scholar
  51. 51.
    Clark KR, Liu X, McGrath JP, Johnson PR (1999) Hum Gene Ther 10:1031 CrossRefGoogle Scholar
  52. 52.
    Gao GP, Qu G, Faust LZ, Engdahl RK, Xiao W, Hughes JV, Zoltick PW, Wilson JM (1998) Hum Gene Ther 9:2353 CrossRefGoogle Scholar
  53. 53.
    Zhang X, Li CY (2001) Mol Ther 3:787 CrossRefGoogle Scholar
  54. 54.
    Conway JE, Rhys CM, Zolotukhin I, Zolotukhin S, Muzyczka N, Hayward GS, Byrne BJ (1999) Gene Ther 6:986 Google Scholar
  55. 55.
    Qiao C, Wang B, Zhu X, Li J, Xiao X (2002) J Virol 76:13015 CrossRefGoogle Scholar
  56. 56.
    Inoue N, Russell DW (1998) J Virol 72:7024 Google Scholar
  57. 57.
    Urabe M, Ding C, Kotin RM (2002) Hum Gene Ther 13:1935 CrossRefGoogle Scholar
  58. 58.
    Sambrook J, Russell DW (eds)(2001) Cesium chloride and cesium chloride equilibrium density gradients. In: Molecular cloning: A laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, New York, pp 1.154–155 Google Scholar
  59. 59.
    Wistuba A, Kern A, Weger S, Grimm D, Kleinschmidt JA (1997) J Virol 71:1341 Google Scholar
  60. 60.
    Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N (1999) Gene Ther 6:973 Google Scholar
  61. 61.
    Summerford C, Samulski RJ (1998) J Virol 72:1438 Google Scholar
  62. 62.
    Gao G, Qu G, Burnham MS, Huang J, Chirmule N, Joshi B, Yu QC, Marsh JA, Conceicao CM, Wilson JM (2000) Hum Gene Ther 11:2079 CrossRefGoogle Scholar
  63. 63.
    Kaludov N, Handelman B, Chiorini JA (2002) Hum Gene Ther 13:1235 CrossRefGoogle Scholar
  64. 64.
    Xie Q, Bu W, Bhatia S, Hare J, Somasundaram T, Azzi A, Chapman MS (2002) P Natl Acad Sci USA 99:10405 CrossRefGoogle Scholar
  65. 65.
    Rabinowitz JE, Xiao W, Samulski RJ (1999) Virology 265:274 CrossRefGoogle Scholar
  66. 66.
    Wu P, Xiao W, Conlon T, Hughes J, Agbandje-McKenna M, Ferkol T, Flotte T, Muzyczka N (2000) J Virol 74:8635 CrossRefGoogle Scholar
  67. 67.
    Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, Deleage G, Hallek M (1999) Nat Med 5:1052 CrossRefGoogle Scholar
  68. 68.
    Grifman M, Trepel M, Speece P, Gilbert LB, Arap W, Pasqualini R, Weitzman MD (2001) Mol Ther 3:964 CrossRefGoogle Scholar
  69. 69.
    Tsao J, Chapman MS, Agbandje M, Keller W, Smith K, Wu H, Luo M, Smith TJ, Rossmann MG, Compans RW et al. (1991) Science 251:1456 CrossRefGoogle Scholar
  70. 70.
    Hileman RE, Fromm JR, Weiler JM, Linhardt RJ (1998) Bioessays 20:156 CrossRefGoogle Scholar
  71. 71.
    Mulloy B, Linhardt RJ (2001) Curr Opin Struct Biol 11:623 CrossRefGoogle Scholar
  72. 72.
    Opie SR, Warrington KH Jr, Agbandje-McKenna M, Zolotukhin S, Muzyczka N (2003) J Virol 77:6995 CrossRefGoogle Scholar
  73. 73.
    Kern A, Schmidt K, Leder C, Muller OJ, Wobus CE, Bettinger K, Von der Lieth CW, King JA, Kleinschmidt JA (2003) J Virol 77:11072 CrossRefGoogle Scholar
  74. 74.
    Buning H, Ried MU, Perabo L, Gerner FM, Huttner NA, Enssle J, Hallek M (2003) Gene Ther 10:1142 Google Scholar
  75. 75.
    Bartlett JS, Kleinschmidt J, Boucher RC, Samulski RJ (1999) Nat Biotechnol 17:181 CrossRefGoogle Scholar
  76. 76.
    Ponnazhagan S, Mahendra G, Kumar S, Thompson JA, Castillas M Jr (2002) J Virol 76:12900 CrossRefGoogle Scholar
  77. 77.
    Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, Deleage G, Hallek M (1999) Nat Med 5:1438 CrossRefGoogle Scholar
  78. 78.
    Nicklin SA, Buening H, Dishart KL, de Alwis M, Girod A, Hacker U, Thrasher AJ, Ali RR, Hallek M, Baker AH (2001) Mol Ther 4:174 CrossRefGoogle Scholar
  79. 79.
    Shi W, Bartlett JS (2003) Mol Ther 7:515 CrossRefGoogle Scholar
  80. 80.
    Work LM, Nicklin SA, Brain NJ, Dishart KL, Von Seggern DJ, Hallek M, Buning H, Baker AH (2004) Mol Ther 9:198 CrossRefGoogle Scholar
  81. 81.
    White SJ, Nicklin SA, Buning H, Brosnan MJ, Leike K, Papadakis ED, Hallek M, Baker AH (2004) Circulation 109:513 CrossRefGoogle Scholar
  82. 82.
    Shi W, Arnold GS, Bartlett JS (2001) Hum Gene Ther 12:1697 CrossRefGoogle Scholar
  83. 83.
    Loiler SA, Conlon TJ, Song S, Tang Q, Warrington KH, Agarwal A, Kapturczak M, Li C, Ricordi C, Atkinson MA, Muzyczka N, Flotte TR (2003) Gene Ther 10:1551 Google Scholar
  84. 84.
    Nicklin SA, Dishart KL, Buening H, Reynolds PN, Hallek M, Nemerow GR, von Seggern DJ, Baker AH (2003) Cancer Lett 201:165 Google Scholar
  85. 85.
    Muller OJ, Kaul F, Weitzman MD, Pasqualini R, Arap W, Kleinschmidt JA, Trepel M (2003) Nat Biotechnol 21:1040 CrossRefGoogle Scholar
  86. 86.
    Perabo L, Buning H, Kofler DM, Ried MU, Girod A, Wendtner CM, Enssle J, Hallek M (2003) Mol Ther 8:151 CrossRefGoogle Scholar
  87. 87.
    Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF (2000) J Clin Invest 105:1573 CrossRefGoogle Scholar
  88. 88.
    Qing K, Hansen J, Weigel-Kelley KA, Tan M, Zhou S, Srivastava A (2001) J Virol 75:8968 CrossRefGoogle Scholar
  89. 89.
    Thomas CE, Storm TA, Huang Z, Kay MA (2004) J Virol 78:3110 CrossRefGoogle Scholar
  90. 90.
    Bantel-Schaal U, Hub B, Kartenbeck J (2002) J Virol 76:2340 CrossRefGoogle Scholar
  91. 91.
    Gao G, Alvira MR, Somanathan S, Lu Y, Vandenberghe LH, Rux JJ, Calcedo R, Sanmiguel J, Abbas Z, Wilson JM (2003) P Natl Acad Sci USA 100:6081 CrossRefGoogle Scholar
  92. 92.
    Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X, Wilson JM (2004) J Virol 78:6381 CrossRefGoogle Scholar
  93. 93.
    Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM (2002) P Natl Acad Sci USA 99:11854 CrossRefGoogle Scholar
  94. 94.
    Hildinger M, Auricchio A, Gao G, Wang L, Chirmule N, Wilson JM (2001) J Virol 75:6199 CrossRefGoogle Scholar
  95. 95.
    Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, Wilson JM (1999) J Virol 73:3994 Google Scholar
  96. 96.
    Erles K, Sebokova P, Schlehofer JR (1999) J Med Virol 59:406 CrossRefGoogle Scholar
  97. 97.
    Georg-Fries B, Biederlack S, Wolf J, zur Hausen H (1984) Virology 134:64 CrossRefGoogle Scholar
  98. 98.
    Xiao X, Li J, Samulski RJ (1996) J Virol 70:8098 Google Scholar
  99. 99.
    Hernandez YJ, Wang J, Kearns WG, Loiler S, Poirier A, Flotte TR (1999) J Virol 73:8549 Google Scholar
  100. 100.
    Brockstedt DG, Podsakoff GM, Fong L, Kurtzman G, Mueller-Ruchholtz W, Engleman EG (1999) Clin Immunol 92:67 CrossRefGoogle Scholar
  101. 101.
    Kaspar BK, Vissel B, Bengoechea T, Crone S, Randolph-Moore L, Muller R, Brandon EP, Schaffer D, Verma IM, Lee KF, Heinemann SF, Gage FH (2002) P Natl Acad Sci USA 99:2320 CrossRefGoogle Scholar
  102. 102.
    Chao H, Monahan PE, Liu Y, Samulski RJ, Walsh CE (2001) Mol Ther 4:217 CrossRefGoogle Scholar
  103. 103.
    Chao H, Liu Y, Rabinowitz J, Li C, Samulski RJ, Walsh CE (2000) Mol Ther 2:619 CrossRefGoogle Scholar
  104. 104.
    Grimm D, Zhou S, Nakai H, Thomas CE, Storm TA, Fuess S, Matsushita T, Allen J, Surosky R, Lochrie M, Meuse L, McClelland A, Colosi P, Kay MA (2003) Blood 102:2412 CrossRefGoogle Scholar
  105. 105.
    Mingozzi F, Schuttrumpf J, Arruda VR, Liu Y, Liu YL, High KA, Xiao W, Herzog RW (2002) J Virol 76:10497 CrossRefGoogle Scholar
  106. 106.
    Flotte T, Agarwal A, Wang J, Song S, Fenjves ES, Inverardi L, Chesnut K, Afione S, Loiler S, Wasserfall C, Kapturczak M, Ellis T, Nick H, Atkinson M (2001) Diabetes 50:515 CrossRefGoogle Scholar
  107. 107.
    Prasad KM, Yang Z, Bleich D, Nadler JL (2000) Gene Ther 7:1553 Google Scholar
  108. 108.
    Wang AY, Peng PD, Ehrhardt A, Storm TA, Kay MA (2004) Hum Gene Ther 15:405 CrossRefGoogle Scholar
  109. 109.
    Du L, Kido M, Lee DV, Rabinowitz JE, Samulski RJ, Jamieson SW, Weitzman MD, Thistlethwaite PA (2004) Mol Ther 10:604 CrossRefGoogle Scholar
  110. 110.
    Beck SE, Jones LA, Chesnut K, Walsh SM, Reynolds TC, Carter BJ, Askin FB, Flotte TR, Guggino WB (1999) J Virol 73:9446 Google Scholar
  111. 111.
    Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD (2000) J Virol 74:1524 CrossRefGoogle Scholar
  112. 112.
    Halbert CL, Allen JM, Miller AD (2001) J Virol 75:6615 CrossRefGoogle Scholar
  113. 113.
    Zabner J, Seiler M, Walters R, Kotin RM, Fulgeras W, Davidson BL, Chiorini JA (2000) J Virol 74:3852 CrossRefGoogle Scholar
  114. 114.
    Flotte T, Carter B, Conrad C, Guggino W, Reynolds T, Rosenstein B, Taylor G, Walden S, Wetzel R (1996) Hum Gene Ther 7:1145 CrossRefGoogle Scholar
  115. 115.
    Wagner JA, Reynolds T, Moran ML, Moss RB, Wine JJ, Flotte TR, Gardner P (1998) Lancet 351:1702 CrossRefGoogle Scholar
  116. 116.
    Wagner JA, Messner AH, Moran ML, Daifuku R, Kouyama K, Desch JK, Manley S, Norbash AM, Conrad CK, Friborg S, Reynolds T, Guggino WB, Moss RB, Carter BJ, Wine JJ, Flotte TR, Gardner P (1999) Laryngoscope 109:266 CrossRefGoogle Scholar
  117. 117.
    Wagner JA, Nepomuceno IB, Messner AH, Moran ML, Batson EP, Dimiceli S, Brown BW, Desch JK, Norbash AM, Conrad CK, Guggino WB, Flotte TR, Wine JJ, Carter BJ, Reynolds TC, Moss RB, Gardner P (2002) Hum Gene Ther 13:1349 CrossRefGoogle Scholar
  118. 118.
    Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ, Humphries M (2004) Hum Gene Ther 15:93 CrossRefGoogle Scholar
  119. 119.
    Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR, Tai SJ, Ragni MV, Thompson A, Ozelo M, Couto LB, Leonard DG, Johnson FA, McClelland A, Scallan C, Skarsgard E, Flake AW, Kay MA, High KA, Glader B (2003) Blood 101:2963 CrossRefGoogle Scholar
  120. 120.
    Vincent KA, Moore GK, Haigwood NL (1990) Vaccine 90:353 Google Scholar
  121. 121.
    Edelstein M (2005) The Journal of Gene Medicine clinical trial website. Wiley, New York (see , last accessed 19th September 2005)
  122. 122.
    Avigen, Inc. (2005) Website. Avigen Inc., Alameda, CA (see , last accessed 19th September 2005)
  123. 123.
    Neurologix, Inc. (2005) Website. Neurologix, Inc., Fort Lee, NJ (see , last accessed 19th September 2005)
  124. 124.
    Flotte TR (2004) Preclinical and phase I/II clinical trials of recombinant adeno-associated virus (rAAV)-alpha-1 antitrypsin vectors. In: Xth Parvovirus Workshop, 8–12 September 2004, St. Petersburg, FL Google Scholar
  125. 125.
    Ceregene, Inc. (2005) Website. Ceregene, Inc., San Diego, CA (see , last accessed 19th September 2005)

Authors and Affiliations

  1. 1.University of North Carolina Gene Therapy CenterChapel HillUSA

Personalised recommendations